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Abstract
AIM: To investigate whether the small bowel transit 
time (SBTT) influences the diagnostic yield of capsule 
endoscopy (CE). 
METHODS: Six hundred and ninety-one consecutive CE 
procedures collected in a database were analyzed. SBTT 
and CE findings were recorded. A running mean for the 
SBTT was calculated and correlated to the diagnostic 
yield with a Spearman’s correlation test. Subgroup anal-
yses were performed for the various indications for the 
procedure. 
RESULTS: There was a positive correlation between 
the diagnostic yield and SBTT (Spearman’s rho 0.58, P  
< 0.01). Positive correlations between diagnostic yield 
and SBTT were found for the indication obscure gastro-
intestinal bleeding (r  = 0.54, P  < 0.01), for polyposis 
and carcinoid combined (r  = 0.56, P  < 0.01) and for 
the other indications (r = 0.90, P  <0.01), but not for 
suspected Crohn’s disease (r  = -0.40).
CONCLUSION: The diagnostic yield in small bowel 
capsule endoscopy is positively correlated with the 
small bowel transit time. This is true for all indications 
except for suspected Crohn’s disease.
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
Capsule endoscopy (CE) is a very sensitive diagnostic 
technique to detect small bowel pathology. It has a higher 
diagnostic yield than conventional diagnostic methods, i.e., 
push enteroscopy, small-bowel follow-through, conven-
tional CT and angiography[1]. The reported diagnostic yield 
of  CE varies between 38% and 83%[2-11]. In 15%-20% of  
all CE’s the capsule does not reach the cecum within re-
cording time. Risk factors for incomplete CE procedures 
include previous small-bowel surgery, hospitalization, mod-
erate or poor bowel cleansing, and a gastric transit time 
longer than 45 min[12].
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bowel, the capsule should reach the cecum within record-
ing time, which is eight to eleven hours depending on the 
manufacturer. Therefore, some investigators use a proki-
netic agent to speed up the gastric and small bowel tran-
sit. However, the short bowel transit time (SBTT) may 
influence the diagnostic yield of  CE. With colonoscopy, 
the detection rate of  neoplastic lesions is higher when 
the time to withdraw the colonoscope is longer[13-15]. It is 
conceivable that a similar principle also applies for small 
bowel CE. We therefore hypothesize that the diagnostic 
yield of  CE depends on the small bowel transit time. To 
study this, we analyzed the influence of  small bowel tran-
sit time on the diagnostic yield of  CE in 691 consecutive 
procedures performed in our department.
MATERIALS AND METHODS
Data from all consecutive CE studies performed at the 
University Medical Center Groningen, the Netherlands, 
between September 2003 and January 2009 were col-
lected. Data that were collected included patient demo-
graphics, indications for the procedure, procedural data, 
including gastric transit time (GTT) and SBTT, and find-
ings of  the procedure. The GTT was defined as the time, 
in minutes, from the first image of  the stomach until the 
first image of  the duodenum. The SBTT was defined as 
the passage time, in minutes, from the first image of  the 
duodenum until the first image of  the cecum. If  the cap-
sule did not reach the cecum within recording time, the 
SBTT was recorded as the time during which small bowel 
images were captured. CE was considered complete 
when the cecum was reached within recording time.
CE procedure
During the study period, all patients received bowel prep-
aration. Patients were given standardized instructions be-
fore the procedure, and informed consent was obtained. 
The patients were asked to stop iron supplements seven 
days before CE and to use a low-fiber diet three days be-
fore CE. The patients started a fasting period at midnight 
before the procedure. Bowel preparation consisted of  
the ingestion of  four liters of  a polyethylene glycol solu-
tion (Colofort®), 3 L the evening before the procedure 
and 1 L in the morning. The capsule (Pillcam; Given 
Imaging Ltd, Yoqneam, Israel) was swallowed in the 
morning. The patients were allowed to drink fluids after 
three hours and to consume a light meal after five hours. 
Before capsule ingestion, 10 mL of  antifoam and a pro-
kinetic agent was given, 10 mg of  domperidone (before 
July 1st 2008, n = 641) or 250 mg of  erythromycin (after 
July 1st 2008, n = 50). All CE recordings were reviewed 
by two gastroenterologists, experienced with CE (RKW 
and JJK). Controversial findings were discussed, and con-
sensus was reached upon the final diagnosis. The most 
relevant findings obtained from CE were documented 
and categorized according to standard terminology[16] 
as angiectasia(s); ulcer(s); bleeding of  unknown origin; 
erosion (s); polyp(s)/tumor(s); incidental abnormality of  
esophagus, stomach, or colon; no abnormality; or unable 
to make a diagnosis.
Statistical analysis
The SBTT was not normally distributed (tested with a 
Kolmogorov-Smirnov test) in the study population. To 
demonstrate the correlation between average diagnostic 
yield and average SBTT, the average yield was calculated 
of  50 consecutive transit times and plotted. Diagnostic 
yield was expressed as 0 for absence of  abnormalities and 
1 for presence of  abnormalities. In this way, a running 
mean for the SBTT was calculated for 50 consecutive pa-
tients and correlated to the diagnostic yield with a Spear-
man’s correlation test. A rho’s correlation coefficient was 
calculated. Comparison of  SBTT between groups was 
performed using a Mann-Whitney U test.
Subgroup analyses were performed for the various 
indications for the procedure. P-values below 0.05 were 
considered significant. SPSS 14.0 for Windows software 
(SPSS Inc., Chicago, IL, United States) and Microsoft Of-
fice Excel 2003 were used for statistical analyses.
RESULTS
Six hundred and ninety-one consecutive CE procedures 
were analyzed. The mean age of  the patients was 54 years 
(range 9-93, SD 18 years). 55% of  the patients were male. 
Indications for CE were obscure gastrointestinal bleeding 
(OGIB) (67%), suspected Crohn’s disease (22%), polypo-
sis (4%), carcinoid (3%) and other (4%). CE findings were 
as follows in the investigated patients: angiectasia(s) in 121 
cases (18%), ulcer(s) in 42 (6%), erosion(s) in 83 (12%), 
bleeding of  unknown origin in 30 (4%), polyp(s)/tumor(s) 
in 56 (8%), abnormality of  esophagus, stomach, or colon 
in 15 (2%), stenosis in 2 (0.3 %), unable to make a diag-
nosis in 6 (1%) and no abnormalities in 336 cases (48%). 
Overall, the diagnostic yield was 51%. 
The cecum was reached in 82% of  all procedures. The 
overall median small bowel transit time was 246 min (25 
and 75 percentiles: 190 and 342). In CE cases with posi-
tive findings, the median SBTT was 254 min (25 and 75 
percentiles: 200 and 361), in negative CE procedures, the 
median SBTT was 239 (25 and 75 percentiles 178 and 
320), this difference was significant (P = 0.012). There 
was a positive correlation between the diagnostic yield and 
SBTT (Figure 1) indicating that the longer the SBTT, the 
higher the diagnostic yield (Spearman’s rho 0.58, P < 0.01).
Next, patients were excluded in whom the cecum 
was not reached (n = 125) within recording time, leaving 
566 procedures with complete visualization of  the small 
intestine. The overall median SBTT was 233 min (25 and 
75 percentiles: 178 and 295). In cases with positive find-
ings, the median SBTT was 236 (25 and 75 percentiles: 
186 and 300), in negative CE procedures the median 
SBTT was 229 min (25 and 75 percentiles: 121 and 281), 
this difference was not significant (P = 0.078). A positive 
correlation was again observed between the diagnostic 
yield and SBTT (Spearman’s rho 0.40, P < 0.01, Figure 2). 
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Subgroup analysis for the different indications was 
performed for OGIB, suspected Crohn’s disease, polypo-
sis and carcinoid combined and other indications. The 
indications polyposis and carcinoid were taken together 
because both groups were too small for separate sub-
group analysis. For these indications, positive correla-
tions between diagnostic yield and SBTT were found for 
OGIB (r = 0.54, P < 0.01), for polyposis plus carcinoid (r 
= 0.56, P < 0.01) and for the other indications (r = 0.90, 
P < 0.01). However this was not observed for Crohn’s 
disease (r = -0.40). These results are depicted in Figure 3.
DISCUSSION
In this study, we found a positive correlation between the 
diagnostic yield of  CE and small bowel transit time, ir-
respective of  whether the capsule had reached the cecum 
within recording time. These findings are in accordance 
with those from colonoscopy studies, which show higher 
diagnostic yields for detecting neoplastic lesions when 
the withdrawal time during colonoscopy is longer[10-13] 
and from one previous study on the effect of  SBTT on 
the diagnostic yield of  CE[17]. Most of  these colonoscopy 
studies divided the withdrawal time into more or less 
than a chosen number of  minutes. In CE there are no 
known standard SBTT times, so we judged that it would 
not be correct to randomly divide the SBTT in two or 
more randomly chosen groups. Therefore we calculated a 
running mean to determine whether the diagnostic yield 
correlated with the SBTT. We found a positive correla-
tion between the two, meaning that a longer transit time, 
implicating more images of  the small bowel, resulted in a 
higher diagnostic yield.
For colonoscopy, the correlation between diagnos-
tic yield and withdrawal time was only investigated in 
subjects undergoing screening for neoplastic lesions. In 
this study we looked at all indications for CE. We found 
a positive correlation between the diagnostic yield and 
SBTT for the indications OGIB and polyposis/carcinoid 
and for other indications, but not for the indication sus-
pected Crohn’s disease. The latter is probably due to the 
multiple and widespread small bowel lesions usually seen 
in Crohn’s disease. Therefore the endoscopist may be less 
dependent upon the mucosal inspection time to make the 
diagnosis. Furthermore, a previous study showed reduced 
capsule transit times in Crohn’s disease[18].
What does this positive correlation between diagnos-
tic yield and SBTT mean for clinical practice? CE is less 
valuable when the cecum is not reached within recording 
time, but on the other hand our study indicates that the 
diagnostic yield is lower when the SBTT is shorter. So, 
ideally, the SBTT should be as long as possible, yet the 
capsule should reach the cecum within recording time. 
The development of  capsule systems with longer battery 
times may be helpful. One important issue in this mat-
ter is whether there is a role for prokinetic agents in CE. 
In this way, one could influence the small bowel transit 
time. There is no consensus on this subject[1]. In most of  
the available studies, there are no data on the influence 
of  prokinetics on the diagnostic yield of  CE. Taking our 
data into account, it may not be wise to use prokinetics 
that speed up the SBTT. However this must be weighed 
against the fact that a prolonged GTT is a risk factor for 
incomplete CE[12]. It may therefore be useful to use an 
agent which shortens GTT without influencing SBTT.
A well known prokinetic agent is erythromycin. It 
induces high amplitude gastric propulsive contractions 
by activating gastric interdigestive migrating motor com-
plexes, thereby accelerating gastric emptying[19-22]. The ef-
fects of  erythromycin on SBTT are unclear. In the most 
recent publication on this subject, erythromycin reduced 
the GTT but had no significant effect on SBTT, total 
bowel transit time and CE completing rates[22]. Previous 
studies found similar results[23,24], but in one at the cost of  
visibility[24]. Others found no effect of  erythromycin on 
either GTT or SBTT[25]. Overall, the data are not very ro-























0           100          200          300          400         500
                           SBTT in minutes
Figure 1  Correlation between the small bowel transit time in minutes and 
the diagnostic yield for all patients. Spearman’s rho coefficient 0.58 ( P < 
0.01) shown by the black line. The trend of this correlation is shown by the red 
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Figure 2  Correlation between the small bowel transit time in minutes and 
the diagnostic yield in patient with complete capsule endoscopy. Spearman’
s rho coefficient 0.40 (P < 0.01) shown by the black line. The trend of this correla-
tion is shown by the red line. DY: Diagnostic yield; SBTT: Small bowel transit time.
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use of  an appropriate statistical method for determining 
the relation between diagnostic yield and SBTT by using 
a running mean.
A limitation of  this study is that all patients in our 
population received a prokinetic agent, which might have 
changed the SBTT and with that also the diagnostic yield. 
The diagnostic yield might have been higher in this study 
population when we would not have used a prokinetic 
agent. Another limitation of  this study is that during 
this study period we switched our prokinetic agent from 
domperidone to erythromycin. One should realize that 
this is a retrospective study. Prospective studies are neces-
sary to establish the effect of  the use of  prokinetics on 
SBTT and diagnostic yield.
There may be many factors that influence SBTT and 
thereby diagnostic yield in small bowel CE. In this study 
we did not analyze such other factors, mainly because the 
main goal of  this study was to determine whether there 
was a relation between diagnostic yield and SBTT at all. 
A previous study on the effect of  SBTT on diagnostic 
yield found an independent association between diagnos-
tic yield and SBTT[17]. In that study, no relation was found 
between diagnostic yield and other potential risk factors 
such as age, gender, study indication, hospital status, and 
bust. If  erythromycin mainly influences GTT, it might be 
an interesting prokinetic agent to use prior to small bowel 
CE. 
Other prokinetics that have been studied in CE are 
metoclopramide and mosapride. Both prokinetic agents 
accelerated GTT and increased capsule completion rates, 
but had no influence on SBTT[26,27]. In our study, we used 
domperidone as a prokinetic agent in the majority of  pa-
tients. Domperidone has shown to be effective in treating 
diabetic gastroparesis[28], but there are no data on the use 
this agent in CE. 
Another way to use prokinetics may be with the aid 
of  a real-time viewer system. In this way, prokinetics (or 
water or additional PEG) can be administered when the 
real-time viewer shows delayed gastric emptying. There 
are three studies that show a higher diagnostic yield of  
CE when a real-time viewer is used with on-demand ad-
ministration of  prokinetics, water, PEG or endoscopic-
assisted duodenal placement[29-31].
The strength of  this study is that this the first study 
that investigated the relation between diagnostic yield of  
CE and SBTT in a large study population. This allowed 
for a subgroup analysis for the different indications of  
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Figure 3  Correlations between small bowel transit time and diagnostic yield. A: Obscure gastrointestinal bleeding (OGIB; r = 0.54, P < 0.01); B: Suspected 
Crohn’s disease (r = -0.40); C: Polyposis plus carcinoid (r = 0.56, P < 0.01); D: Other indications (r = 0.90, P < 0.01), shown by the black line. The trend of this correla-
tion is shown by the red line. DY: Diagnostic yield; SBTT: Small bowel transit time.
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quality of  bowel preparation[17]. Since we also found a 
positive correlation between diagnostic yield and SBTT 
it might be very interesting to look further into factors 
influencing SBTT and thereby diagnostic yield in future 
studies.
In conclusion, in this study with a large group of  pa-
tients, we found a positive correlation between the diagnos-
tic yield of  small bowel CE and small bowel transit time 
for all indications except for suspected Crohn’s disease. 
For clinical practice, these data implicate that it may not be 
advisable to use prokinetic agents which accelerate small 




Capsule endoscopy (CE) is a very sensitive diagnostic technique to detect 
small bowel pathology. For a good and complete evaluation of the small bowel, 
the capsule should reach the cecum within recording time which is eight to 
eleven hours depending on the manufacturer. Some investigators advocate 
the use of a prokinetic agent to speed up the gastric and small bowel transit. 
However, a short bowel transit time (SBTT) may influence the diagnostic yield 
of CE. With colonoscopy, the detection rate of neoplastic lesions is higher when 
the time to withdraw the colonoscope is longer. It is conceivable that a similar 
principle also applies for small bowel CE. Therefore the question is whether the 
diagnostic yield of CE depends on the small bowel transit time.
Research frontiers
This the first study that investigated the relation between diagnostic yield of CE 
and SBTT in a large study population. This possible relation was also investi-
gated for different indications for CE. 
Innovations and breakthroughs
Six hundred and ninety-one consecutive CE procedures were analyzed. This 
study found a positive correlation between the diagnostic yield of CE and small 
bowel transit time, irrespective of whether the capsule had reached the cecum 
within recording time. These findings are in accordance with those from colo-
noscopy studies. This means that a longer transit time, implicating more images 
of the small bowel, resulted in a higher diagnostic yield. We found a positive 
correlation between the diagnostic yield and SBTT for all indications except for 
suspected Crohn’s disease. The latter is probably due to the multiple and wide-
spread small bowel lesions usually seen in Crohn’s disease.
Applications
What does this positive correlation between diagnostic yield and SBTT mean 
for clinical practice? CE is less valuable when the cecum is not reached within 
recording time, but on the other hand our study indicates that the diagnostic 
yield is lower when the SBTT is shorter. So, ideally, the SBTT is long, but not so 
long that the capsule does not reach the cecum within recording time. One im-
portant issue in this matter is whether there is a role for prokinetic agents in CE 
to influence small bowel transit time. There is no consensus in the literature on 
this subject. For clinical practice, these data implicate that it may not be advis-
able to use prokinetic agents which accelerate small bowel transit, although this 
remains to be proven in future studies.
Peer review
It is a nice and interesting work. It values an important aspect of the capsule 
endoscopy not well studied until now: the relation between the diagnostic yield 
of capsule endoscopy and small bowel transit time.
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